Hospital de la Santa Creu i Sant Pau

Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema (2025) Haas Y, Williams OP, Masia J, Pons G, Taylor EM, Katapodi MC, Staub D, et al. Journal article Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage (2025) Goeldlin MB, Fandler-Höfler S, Pezzini A, Manikantan A, Rauch J, Hald SM, Kristensen ML, et al. Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells (2024) Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, et al. Journal article p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (2023) Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, et al. Journal article, Original article EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis (2023) Zabotti A, De Marco G, Gossec L, Baraliakos X, Aletaha D, Iagnocco A, Gisondi P, et al. Journal article Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review (2023) Gisondi P, Simon D, Alarcon I, Pournara E, Puig L Journal article, Review article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution